Mahesh Asawa Chandra
Direktor/Vorstandsmitglied bei Unidrug Innovative Pharma Technologies Ltd.
Profil
Mahesh Asawa Chandra is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and a Fellow Member at The Institute of Chartered Accountants of India.
He has an undergraduate and graduate degree from Devi Ahilya University.
Aktive Positionen von Mahesh Asawa Chandra
Unternehmen | Position | Beginn |
---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Direktor/Vorstandsmitglied | 20.09.2018 |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Ausbildung von Mahesh Asawa Chandra
Devi Ahilya University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |